Cite
HARVARD Citation
Jang, J. et al. (2021). Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open‐label study. British journal of haematology. pp. 190-199. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jang, J. et al. (2021). Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open‐label study. British journal of haematology. pp. 190-199. [Online].